If you liked this article you might like

Biotech Premarket Movers: Impax, Clearside Biomedical, Mylan
CVS Remains Unsure About the Future of Obamacare, CEO Says
Mylan's Shares Rise Despite FTC Investigation
Express Scripts, Cigna Opt Out of Paying for EpiPen Competitor Auvi-Q